Concepedia

Mohit D. Gandhi

MD

Statistics

Publications

6

Citations

382

H-Index

6

Active since

2002

Affiliations

University of Missouri–Kansas City(Current)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Sweden)

Mohit D. Gandhi is an author at University of Missouri–Kansas City specializing in pharmacology, life sciences, and pharmacokinetics.

Publications per year

2002–2018

6

Publications

6

Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils

Todd G. Kirchgessner, Paul G. Sleph, Jacek Ostrowski et al. · Cell Metabolism · 2016 · 164 citations · Full text

, , +17

Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban

Charles Frost, Andrew Shenker, Mohit D. Gandhi et al. · British Journal of Clinical Pharmacology · 2014 · 60 citations · Full text

, , +13

A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects

Orit Cohen‐Barak, Sivan Weiss, Michèle Rasamoelisolo et al. · Cephalalgia · 2018 · 54 citations

, , +15

Effect of P-glycoprotein on the ocular disposition of a model substrate, quinidine

Sridhar Duvvuri, Mohit D. Gandhi, Ashim K. Mitra · Current Eye Research · 2003 · 44 citations

, , +17

Transport of HIV-Protease Inhibitors Across 1α,25di-Hydroxy Vitamin D3-Treated Calu-3 Cell Monolayers: Modulation of P-Glycoprotein Activity

Jignesh Patel, Dhananjay Pal, Veena Vangala et al. · Pharmaceutical Research · 2002 · 34 citations

, , +13

1–5 of 6